News for 'Pfizer BioNTech'

Over 1 million new COVID-19 cases reported in US

Over 1 million new COVID-19 cases reported in US

Rediff.com4 Jan 2022

The US health authorities registered more than three times as many new cases as in any previous wave of the coronavirus.

US President-elect Biden publicly receives COVID-19 vaccine

US President-elect Biden publicly receives COVID-19 vaccine

Rediff.com22 Dec 2020

Biden received the first course of the Pfizer-BioNTech vaccine at ChristianaCare Hospital in Newark, Delaware.

Oxford's COVID vaccine 'encouraging' for older age groups

Oxford's COVID vaccine 'encouraging' for older age groups

Rediff.com19 Nov 2020

This means there are now four promising vaccines on the horizon after Pfizer-BioNTech, Sputnik and Moderna already reporting good preliminary data from Phase 3 trials.

'India examining possibilities': Govt on Pfizer Covid vaccine

'India examining possibilities': Govt on Pfizer Covid vaccine

Rediff.com17 Nov 2020

The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.

Are you brave enough to get vaccinated at Dracula's castle?

Are you brave enough to get vaccinated at Dracula's castle?

Rediff.com12 May 2021

Castle staff hope the service will bring more people to the site in Romania's Carpathian mountains, where tourist numbers have plummeted since the start of the pandemic.

US: First batch of COVID-19 vaccine roll out of Pfizer plant

US: First batch of COVID-19 vaccine roll out of Pfizer plant

Rediff.com14 Dec 2020

The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

Sputnik V vaccine 92% 'effective' against coronavirus, claims Russia

Sputnik V vaccine 92% 'effective' against coronavirus, claims Russia

Rediff.com11 Nov 2020

The efficacy of the vaccine, developed by the Gamalaya Centre, was demonstrated on the basis of a first interim analysis obtained 21 days after the first injection.

Spain players receive vaccines amid fears of side effects

Spain players receive vaccines amid fears of side effects

Rediff.com11 Jun 2021

Members of the Spanish army administered the vaccines to the squad and coaching staff

Guardiola urges players to get COVID-19 booster shots

Guardiola urges players to get COVID-19 booster shots

Rediff.com14 Dec 2021

Tottenham Hotspur recorded 13 COVID-19 cases at the club last week, while Leicester City and Manchester United were also affected by the virus.

Museums, churches, malls: Unusual vaccination venues

Museums, churches, malls: Unusual vaccination venues

Rediff.com25 May 2021

The distribution of the Covid-19 vaccine is underway across the world. To provide a convenient and safe place for people to receive COVID-19 vaccines, countries around the world transform shopping malls, churches, airports, subway stations and museums to vaccination centers. Some also offer vaccination services on the river and mountain.

WHO nod for Covaxin expected any time now

WHO nod for Covaxin expected any time now

Rediff.com26 Oct 2021

A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.

Double vaccinated 3 times less likely to get COVID: Study

Double vaccinated 3 times less likely to get COVID: Study

Rediff.com6 Aug 2021

PHE estimates that the vaccination programme in England has prevented 22 million infections, around 52,600 hospitalisations and between 35,200 and 60,000 deaths.

London to move to highest alert as new Covid variant identified in UK

London to move to highest alert as new Covid variant identified in UK

Rediff.com15 Dec 2020

The health minister said that experts had identified over 1,000 cases with the variant, predominantly in the south of England.

WHO seeks 'additional clarifications' from Bharat Biotech

WHO seeks 'additional clarifications' from Bharat Biotech

Rediff.com27 Oct 2021

The technical advisory group will now meet on November 3 for a final assessment.

Americans can now go outside without a mask: CDC

Americans can now go outside without a mask: CDC

Rediff.com27 Apr 2021

According to the agency, fully vaccinated people do not need to wear masks during small, outdoor gatherings even if there's a mixture of vaccinated and unvaccinated people.

COVID jab didn't hurt at all, says Britain's Queen

COVID jab didn't hurt at all, says Britain's Queen

Rediff.com26 Feb 2021

In a rare reference to private health matters, the 94-year-old monarch backed the National Health Service led vaccination programme in the UK during a video call earlier this week with health officials coordinating the rollout across England, Wales, Scotland and Northern Ireland.

New UK variant of Covid may be more deadly: Johnson

New UK variant of Covid may be more deadly: Johnson

Rediff.com23 Jan 2021

"In addition to spreading more quickly, it also now appears that there is some evidence that the new variant - the variant that was first identified in London and the south east (of England) -- may be associated with a higher degree of mortality," Johnson said on Friday in his address at a virtual briefing from 10 Downing Street.

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

UK identifies new South African coronavirus variant

UK identifies new South African coronavirus variant

Rediff.com24 Dec 2020

Like the UK variant identified earlier, the new variant of the novel coronavirus is also driving a massive resurgence of the disease in South Africa, with experts warning the country is probably facing a much larger second wave.

Serum Institute seeks regular marketing approval for Covishield

Serum Institute seeks regular marketing approval for Covishield

Rediff.com25 Oct 2021

If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.

When will the uncertainty over Olympics end?

When will the uncertainty over Olympics end?

Rediff.com15 May 2021

The Olympics are set to run from July 23 to Aug. 8 after being postponed in March last year over the coronavirus pandemic.

Confusion over UK nod to vaccinated Indian travellers

Confusion over UK nod to vaccinated Indian travellers

Rediff.com22 Sep 2021

There is confusion over the United Kingdom government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.

Kids will have to wait for a COVID-19 vaccine

Kids will have to wait for a COVID-19 vaccine

Rediff.com28 Dec 2020

The primary objective was to get the adult vaccine as children rarely have a severe form of the disease. Once schools reopen, the demand for vaccines for children under 12 may soar.

UK ends quarantine mandate for Indians vaxxed with Covishield

UK ends quarantine mandate for Indians vaxxed with Covishield

Rediff.com8 Oct 2021

Putting an end to the vaccine certification row, the UK on Thursday announced that Indians, fully vaccinated with Covishield vaccine, will no longer require to undergo quarantine on their arrival in Britain from October 11.

US lifts mask guidance for fully vaccinated people

US lifts mask guidance for fully vaccinated people

Rediff.com14 May 2021

The recommendation holds true for both indoors and outdoors, the CDC said.

54.72 L COVID vaccine doses received till Tuesday afternoon: Centre

54.72 L COVID vaccine doses received till Tuesday afternoon: Centre

Rediff.com12 Jan 2021

Apart from the 1.1 crore doses of Covishield being procured from the Serum Institute of India, 55 lakh doses of indigenously developed Covaxin were being obtained from Bharat Biotech, Union Health Secretary Rajesh Bhushan said at a press conference.

Pressure on UK to review Covid vax rules for Indians

Pressure on UK to review Covid vax rules for Indians

Rediff.com21 Sep 2021

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to recognise Indian vaccines under an expanded list of countries.

At current pace India will inoculate 75% of population only by mid-2024

At current pace India will inoculate 75% of population only by mid-2024

Rediff.com2 Jun 2021

The average rate of COVID-19 vaccination in the country has been 10.8 million per week. At that rate, it will take India till December 2024 to complete two billion doses.

Covishield accounts for 88% of Covid jabs in India

Covishield accounts for 88% of Covid jabs in India

Rediff.com1 Jan 2022

Serum Institute has the capacity to make 250 million doses of Covishield monthly.

Govt needs to define COVID vaccine strategy: Rahul

Govt needs to define COVID vaccine strategy: Rahul

Rediff.com11 Nov 2020

Pfizer Inc and BioNTech SE have said that their vaccine candidate has been found to be more than 90 per cent effective in preventing COVID-19.

Dry run for Covid inoculation next week

Dry run for Covid inoculation next week

Rediff.com26 Dec 2020

An important focus of the dry run will be on management of any possible adverse events following immunisation.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.

Delta variant 'greatest threat' to US Covid response: Dr Fauci

Delta variant 'greatest threat' to US Covid response: Dr Fauci

Rediff.com23 Jun 2021

However, the "good news" is that the US vaccines are effective against the Delta variant, said Fauci, the head of the National Institutes of Allergy and Infectious Diseases.

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

Rediff.com4 Jan 2021

The Oxford vaccine, which also has a tie-up with the Serum Institute of India, was first administered to Brian Pinker, an 82-year-old Oxford-born dialysis patient. Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chief nurse, hailed as a major milestone in the phased vaccination programme being undertaken by the National Health Service (NHS).

'Both vaccines will be similar in immunity'

'Both vaccines will be similar in immunity'

Rediff.com11 Jan 2021

'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'

Dom's Take: The race for COVID-19 vaccine

Dom's Take: The race for COVID-19 vaccine

Rediff.com17 Nov 2020

Dominic Xavier wonders when human beings can access the vaccine and terminate the mayhem caused by the coronavirus.

Sensex hits 43,000-mark for first time; Nifty tops 12,600

Sensex hits 43,000-mark for first time; Nifty tops 12,600

Rediff.com10 Nov 2020

Bajaj Finance was the top gainer in the Sensex pack, surging around 9 per cent, followed by IndusInd Bank, L&T, Bajaj Finserv, HDFC, SBI, ICICI Bank, HDFC Bank, ONGC and Axis Bank. On the other hand, Tech Mahindra, HCL Tech, Infosys, Nestle India, Sun Pharma and TCS closed in the red.

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.

UK hits target to offer every adult COVID jab by July end

UK hits target to offer every adult COVID jab by July end

Rediff.com18 Jul 2021

The Department of Health and Social Care said a total of 81,959,398 doses of COVID vaccines have been administered in the UK, with 46,227,101 people receiving a first dose (87.8 per cent) and 35,732,297 people receiving both doses (67.8 per cent).